News | January 26, 2021
Slow recovery in biosimilars for Biocon: ICICI Securities
Dr Christiane Hamacher, has stepped down as the MD of Biocon Biologics and will be succeeded by Dr Arun Chandavarkar.
Dr Christiane Hamacher, has stepped down as the MD of Biocon Biologics and will be succeeded by Dr Arun Chandavarkar.
EBITDA for the quarter stood at Rs. 427 crore and Net Profit was at Rs. 169 crore. Our Core EBITDA margins stood at 31%.
Biocon Ltd, an innovation-led global biopharmaceuticals company, has announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment of US $75 million (Rs. 555 crores) by Abu Dhabi based ADQ, one of the region’s largest holding companies.
Upgrades 2025 full-year CDMO sales and margin outlook
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
The site, spanning approximately 25,000 square meters, is expected to commence operations by the end of 2025
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs
Subscribe To Our Newsletter & Stay Updated
